InflaRx: Guggenheim Maintains Buy Rating, Raises PT to $22 from $10

Monday, Nov 10, 2025 8:18 am ET1min read
IFRX--

InflaRx: Guggenheim Maintains Buy Rating, Raises PT to $22 from $10

InflaRx: Guggenheim Maintains Buy Rating, Raises PT to $22 from $10

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet